This review examines a way to connect to license before entering clinical trials. Describes Merck decision tree is presented evaluation. Information needed to evaluate a specific licensing opportunity, including the costs of the three stages of the review, the revenue if approved, and the probability of different outcomes. It contains an introduction to decision tree analysis and evaluation.

This review examines a way to connect to license before entering clinical trials. Describes Merck decision tree is presented evaluation. Information needed to evaluate a specific licensing opportunity, including the costs of the three stages of the review, the revenue if approved, and the probability of different outcomes. It contains an introduction to decision tree analysis and evaluation.
«Hide

from
Richard S. Ruback,
David Krieger
Source: HBS Premier Case Collection
6 pages.
Publication Date: Oct 30, 2000. Prod #: 201023-PDF-ENG
Merck & Co.: Evaluating a Drug Licensing Opportunity HBR case solution

[related_post themes="flat"]